Continuing Nursing Education (CNE) Activity: Neonatal Pharmacology

Speaker(s): Jim Thigpen, PharmD, BCPS

Total Contact Hours: 3.75 CH, 3.75 Rx

Intended Audience: All mother baby nurses

Purpose of this CNE activity: The Academy of Neonatal Nursing provides clinically current information on the technical, medical, and nursing aspects of neonatal care as well as the legal and ethical implications related to that care. This CNE activity provides information to nurses and other health care professionals who care for newborn, premature, and ill infants and their families. Specific objectives for this presentation are listed below.

Objectives: Upon completion, learners will be able to:

Describe the current pharmacotherapeutic treatments that are available for the topics discussed.
Identify situations where patient parameters would lead to an alteration of drug therapy.
Evaluate alternative and future pharmacotherapeutic options for application in neonates.

Requirements for Completion: The following requirements are necessary for successful completion of this CNE activity.

Access to a computer with an Internet connection
Attend at least 90 percent of each session
Complete and submit the evaluation for this CNE activity

Accreditation
Provider, Academy of Neonatal Nursing, approved by the California Board of Registered Nursing, Provider #CEP 6261; and Florida Board of Nursing, Provider #FBN 3218, content code 2505.

The Academy of Neonatal Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Release Date: September 8, 2013
Planned Review Date: October, 2016

Disclosures:

The lead nurse planner, the planning committee, and the author(s) of this activity disclose no relevant financial relationships, other than Dana Lunde, who is on the speaker’s bureau for Abbott Nutrition and ONY Medical, Inc.
This CNE activity has been reviewed by the Lead Nurse Planner. It has been determined that the material presented here shows no bias.
The content of this CNE activity has been developed by the planning committee and reviewed by the Lead Nurse Planner. The content has been deemed to reflect the current state of practice.

Disclaimer: The Academy of Neonatal Nursing assumes no responsibility or liability for the content presented. Care of the infant should always be individualized and no one source relied upon for information regarding aspects of care.

In the event that any form of commercial support is provided for an activity, the Academy of Neonatal Nursing maintains control of the educational content and will disclose to the learners all financial relationships or lack thereof, between the commercial supporter and the accredited provider or presenters. Learners are made fully aware of the nature of any commercial support related to an educational activity. The Academy of Neonatal Nursing requires presenters to report any conflict of interest (e.g., financial interest in any medical companies, pharmaceutical company funding or topic-related research), and posts such disclosures on each session page in this book.

Jim Thigpen PharmD. BPCS

Associate Professor of Pharmacy Practice, ETSU Bill Gatton College of Pharmacy

Appearances